Thursday, April 09, 2015 8:36:59 AM
Agree. I also think it will be in $1-$1.5 range and stay there before FDA approval.
Recent DRIO News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/30/2026 10:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/30/2026 04:15:17 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/19/2026 09:03:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/19/2026 09:02:06 PM
- DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results • PR Newswire (US) • 03/19/2026 10:30:00 AM
- DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 • PR Newswire (US) • 03/11/2026 12:30:00 PM
- Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health • PR Newswire (US) • 03/10/2026 12:00:00 PM
- Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management • PR Newswire (US) • 03/03/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 09:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 09:06:11 PM
- Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms • PR Newswire (US) • 01/21/2026 01:00:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/29/2025 09:05:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/22/2025 09:12:29 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/16/2025 10:08:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/11/2025 10:15:51 PM
- Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members • PR Newswire (US) • 12/10/2025 01:00:00 PM
- Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio • PR Newswire (US) • 12/04/2025 01:00:00 PM
- DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year • PR Newswire (US) • 11/24/2025 01:00:00 PM
- DarioHealth Reports Third Quarter 2025 Financial and Operating Results • PR Newswire (US) • 11/13/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 11:05:53 AM
- DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform • PR Newswire (US) • 11/12/2025 01:30:00 PM
